Results 201 to 210 of about 184,454 (263)

Long‐term follow‐up and post‐operative computed tomography surveillance following adrenalectomy in dogs

Australian Veterinary Journal, EarlyView.
Adrenal gland tumours in dogs have historically been associated with a guarded prognosis due to reported high perioperative mortality, recurrence and metastatic disease. More recent studies suggest improved outcomes following adrenalectomy. This retrospective study evaluated long‐term outcomes and postoperative computed tomography (CT) findings in dogs
TR Nash, GL Hosgood
wiley   +1 more source

Partially calcified organized thrombus of the right atrium mimicking a cardiac tumor: a case report. [PDF]

J Surg Case Rep
Taguchi T, Iida S, Yamakura T, Ito Y, Nishi H, Kondoh H.   +5 more
europepmc   +1 more source

Thrombosis and Circulation: From Bench to Bedside

Thrombosis and Circulation Research, EarlyView.
Zhenguo Zhai
wiley   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Prognostic Impact of Residual Thrombus After Aspiration Thrombectomy in ST-Elevation Myocardial Infarction. [PDF]

JACC Asia
Endo T, Higuma T, Yokoyama H, Yokota T, Tomita H.   +4 more
europepmc   +1 more source

Ischaemic stroke and 5‐fluorouracil or capecitabine: A systematic review and meta‐analysis of harms and a retrospective study of the WHO pharmacovigilance database

British Journal of Pharmacology, EarlyView.
Abstract Aim Fluoropyrimidines, including 5‐fluorouracil (5‐FU) and capecitabine, are cornerstone antineoplastic agents for cancer. Case reports suggest that these drugs may be associated with an under‐recognised risk of ischaemic stroke or transient ischaemic attack (TIA).
Sophie Nguyen, Ines Bentahrour, Camille Guerin, Charles Dolladille, Angélique Da Silva, François Cherifi, Elise‐Marie Minoc, Pierre‐Marie Morice, Nicolas Jacquin, Christophe Le Tourneau, Joachim Alexandre, Ahmad Nehme, Etienne Bastien   +12 more
wiley   +1 more source

Giant right atrial thrombus unmasking Behçet's disease: A rare cardiovascular manifestation. [PDF]

Radiol Case Rep
Ait Boutargante H, Eddakhche H, El Houari A, Beladel W, El Baz KA, Berrajaa M, El Minaoui M.   +6 more
europepmc   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source